The objective of the Fund is to preserve capital and achieve longterm capital appreciation by investing worldwide in the shares of biotechnology, diagnostics and life sciences tools companies.The Fund is broadly diversified across countries, biotechnology sectors and by market-cap (a measure of company size).The Fund may invest in financial derivatives (complex instrumentsbased upon the value of underlying assets) for hedging, to reducerisk, to manage the Fund more efficiently, or to gain exposure tosecurities in a more efficient way.